Nuveen Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$48.7M Buy
1,077,794
+273,638
+34% +$12.4M 0.01% 660
2024
Q3
$29.8M Buy
804,156
+117,631
+17% +$4.36M 0.01% 930
2024
Q2
$21M Buy
686,525
+219,865
+47% +$6.72M 0.01% 1100
2024
Q1
$13.6M Buy
466,660
+174,259
+60% +$5.07M ﹤0.01% 1411
2023
Q4
$8.06M Buy
292,401
+82,897
+40% +$2.28M ﹤0.01% 1727
2023
Q3
$4.69M Sell
209,504
-1,780
-0.8% -$39.9K ﹤0.01% 1896
2023
Q2
$8.59M Buy
211,284
+2,032
+1% +$82.6K ﹤0.01% 1600
2023
Q1
$10.1M Buy
209,252
+14,091
+7% +$683K ﹤0.01% 1475
2022
Q4
$7.45M Sell
195,161
-16,209
-8% -$619K ﹤0.01% 1681
2022
Q3
$10.6M Sell
211,370
-2,662
-1% -$134K ﹤0.01% 1438
2022
Q2
$8.57M Sell
214,032
-64,891
-23% -$2.6M ﹤0.01% 1614
2022
Q1
$5.79M Buy
278,923
+71,502
+34% +$1.48M ﹤0.01% 1980
2021
Q4
$4.3M Sell
207,421
-35,905
-15% -$745K ﹤0.01% 2211
2021
Q3
$5.05M Sell
243,326
-9,153
-4% -$190K ﹤0.01% 2206
2021
Q2
$5.24M Buy
252,479
+1,585
+0.6% +$32.9K ﹤0.01% 2220
2021
Q1
$5.21M Sell
250,894
-7,221
-3% -$150K ﹤0.01% 2150
2020
Q4
$5.36M Sell
258,115
-2,914
-1% -$60.5K ﹤0.01% 2037
2020
Q3
$5.42M Sell
261,029
-26,837
-9% -$557K ﹤0.01% 1871
2020
Q2
$5.97M Sell
287,866
-254,368
-47% -$5.28M ﹤0.01% 1802
2020
Q1
$24.2M Sell
542,234
-117,857
-18% -$5.26M 0.01% 801
2019
Q4
$31.7M Buy
660,091
+365,512
+124% +$17.6M 0.01% 916
2019
Q3
$9.96M Buy
294,579
+15,434
+6% +$522K ﹤0.01% 1577
2019
Q2
$12.6M Buy
+279,145
New +$12.6M ﹤0.01% 1458
2015
Q4
Sell
-18,166
Closed -$485 1462
2015
Q3
$485 Buy
+18,166
New +$485 ﹤0.01% 1258
2014
Q3
Sell
-8,758
Closed -$317K 1545
2014
Q2
$317K Buy
+8,758
New +$317K ﹤0.01% 1394